Knowledge, Attitudes and Behaviors of Medical School Students about HPV, HPV Vaccine and Cervical Cancer: A Survey Study in a Medical School

Year 2022, Volume: 32 Issue: 6, 724 - 729, 31.12.2022

Mursel Duzova Sefa Küçükkınalı Amır Emamvırdı Ahmet Tarık Kozak Hacer İlkay Genç Hasan Ali Cırık Şahsenem Beyzanur Şahinkaya Ahmet Mert Ulucan

https://doi.org/10.54005/geneltip.1219410

Abstract

Objective: This study aimed to determine the knowledge, attitudes and behaviors of students in a medical school about HPV, HPV vaccine and cervical cancer.
Methods: The research was carried out in the students of Selcuk University Faculty of Medicine in April 2022. The universe of the study consisted of all medical school students and it was conducted with 125 volunteers who accepted the study. Participants were asked questions about HPV, HPV vaccine and cervical cancer.
Results: One-hundred twenty five students participated in the study. The mean age was 20,89±2,339 (range 18-31). Of the 125 participants, 50,4% (n: 63) were female and 49,6% (n: 62) were male, and 74,4% (n: 93) were preclinical (1-2-3th year) students, and 25,6% (n = 32) were clinical (4-5-6th year) students. Majority of the respondents [ 86.4% (n=108)] reported that they did not have enough knowledge about HPV, HPV vaccine and diseases caused by HPV.
Conclusion: As the result of the study, even medical school students were not fully informed about HPV, HPV vaccine, and cervical cancer. It is extremely important for more healty generation that medical students, who will be the pioneers of healthcare of the future and will educate the public on health and guide health policies, are given adequate training on HPV and HPV vaccine.

Keywords

HPV, HPV vaccine, Cervical Cancer, Survey, Student

Tıp Fakültesi Öğrencilerinin HPV, HPV Aşısı ve Rahim Ağzı Kanseri Hakkında Bilgi, Tutum ve Davranışları: Bir Tıp Fakültesinde Anket Çalışması

Abstract

Amaç: Bu çalışma, bir tıp fakültesinde öğrencilerin, HPV, HPV aşısı ve serviks kanseriyle ilgili bilgi, tutum ve davranışlarını belirlemeyi amaçladı.
Yöntem: Araştırma nisan 2022'de Selçuk Üniversitesi Tıp Fakültesi öğrencilerinde yapıldı. Çalışmanın evrenini tüm tıp fakültesi öğrencileri oluşturdu ve çalışmayı kabul eden 125 gönüllüyle çalışma yapıldı. Katılımcılara HPV, HPV aşısı ve serviks kanseriyle ilgili sorular yönlendirildi.
Bulgular: Araştırmaya yüz yirmi beş öğrenci katılmıştır. Yaş ortalaması 20,89±2,339 (dağılım 18-31) idi. 125 katılımcının %50,4'ü (n:63) kadın, %49,6'sı (n:62) erkek ve %74,4'ü (n:93) preklinik (1-2-3. sınıf) öğrencisiydi ve %25,6'sı (n=32) klinik (4-5-6. sınıf) öğrencisiydi. Ankete katılanların çoğunluğu [%86,4 (n=108)] HPV, HPV aşısı ve HPV'nin neden olduğu hastalıklar hakkında yeterli bilgiye sahip olmadığını bildirdi.
Sonuç: Araştırma sonucunda tıp fakültesi öğrencilerinin bile HPV, HPV aşısı ve rahim ağzı kanseri hakkında tam olarak bilgi sahibi olmadıkları ortaya çıktı. Geleceğin sağlık sektörünün öncüleri olacak, halkı sağlık konusunda eğitecek ve sağlık politikalarına yön verecek tıp öğrencilerine HPV ve HPV aşısı konusunda yeterli eğitim verilmesi daha sağlıklı bir nesiller için son derece önemlidir.

Keywords

HPV, HPV vaccine, Cervical Cancer, Survey, Student

References

• Sung, Hyuna, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2021, 71.3: 209-249.
• TC Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü . https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2017.pdf; Accessed on November 22, 2022
• American Cancer Society. Cervical Cancer Causes, Risk Factors and Prevention https://www.cancer.org/content/dam/CRC/PDF/Public/8600.00.pdf; Accessed date: 21.11.2022
• World Health Organization. Human Papillomavirus (HPV) and cervical cancer. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer;Accessed date:21.11.2022
• World Health Organization. Cervical cancer https://www.who.int/news-room/fact-sheets/detail/cervical-cancer; Accessed date: 21.11.2022
• Quınn, Mike, et al. PapersEffect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Bmj, 1999, 318.7188: 904.
• T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Kanser Dairesi Başkanlığı. https://hsgm.saglik.gov.tr/tr/kanser-taramalari; Accessed date: 21.11.2022
• Duval B, Gilca V, Boulianne N, Pielak K, Halperin B, Simpson MA, Lavoie F. Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions. Journal of Advanced Nursing. 2009; 65(3), 499-508.
• Tafuri S, Martinelli D, Vece MM, Quarto M, Germinario C,Prato R. Communication skills in HPV prevention: an audit among Italian healthcare workers. Vaccine, 2010, 28.34: 5609-5613.
• Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet, 2019; 393(10167), 169-182.
• Beavis AL, Gravitt PE, Rositch AF. Hysterectomy‐corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer, 2017, 123.6: 1044-1050.
• Stang A, Hawk H, Knowlton R, Gershman ST, Kuss, O. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Annals of Epidemiology, 2014, 24.11: 849-854.
• SEER Cancer Stat Facts: Cervix Uteri Cancer. https://seer.cancer.gov/statfacts/html/cervix.html Accessed date: 20.11.2022
• National Cancer Institute. HPV and Cancer. Available at: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer; Accessed date: 21.11.2022
• Gardasil 9 (Human papillomavirus 9-valent vaccine, recombinant. US FDA approved product information; Whitehouse Station, NJ: Merck & Co, Inc. June 2020.
• Centers for Disease Control and Prevention Human papillomavirus (HPV) vaccination information for clinicians Available at: https://www.cdc.gov/vaccines/vpd/hpv/hcp/index.html; Accessed on November 22, 2022
• Laprise J, Chesson HW, Markowitz LE, Drolet M, Martin D, Bénard É, Brisson, M. Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States. Annals of internal medicine, 2020, 172.1: 22-29.
• Güvenç G, Akyüz A, Seven M. Hemşirelik yüksek okulu öğrencilerinin human papilloma virüs enfeksiyonu ve aşıları ile ilgili bilgi ve tutumlarının belirlenmesi. Gulhane Medical Journal, 2012, 54.2.
• Anatolıa AM. Human papilloma virus and HPV vaccine knowledge among Mustafa Kemal University medical students. Acta Med Anatol, 2014, 2.2: 37-41.
• Y Çeşmeci, B Köylü, J Sulaiman, E Sancak, S Şenel…HPV infection and hpv vaccine through the eyes of interns. Turkish J Gynecol Oncol, 2015, 3: 85-92.
• Kılıc D, Dolma E, Güney İ, Acar E, Gür E, Kıdam BN, Güler TÖ. Knowledge level and attitude for Human Papillomavirus (HPV) infection and HPV vaccines among medical school students. Journal of Contemporary Medicine, 2020, 10.3: 394-39